Amgen Inc.

Amgen Research (munich) Gmbh

Daiichi Sankyo Europe Gmbh

Eric Borges

Peter Kufer

Tobias Raum

Mike Rothe

Patrick Hoffmann

Doris Rau

Roman Kischel

Susanne Hipp

Ralf Lutterbuese

Barbara Hebeis

Martin Treder

Susanne Hartmann

Paul Adam

Bob Radinsky

The present invention relates to a binding molecule which is at least bispecific comprising a first and a second binding domain, wherein the first binding domain is capable of binding to epitope cluster 3 of BCMA, and the second binding domain is capable of binding to the T cell CD3 receptor complex. Moreover, the invention provides a nucleic acid sequence encoding the binding molecule, a vector comprising said nucleic acid sequence and a host cell transformed or transfected with said vector. Furthermore, the invention provides a process for the production of the binding molecule of the invention, a medical use of said binding molecule and a kit comprising said binding molecule.

Binding molecules for BCMA and CD3

Growing community of inventors

Munich, Germany

Eric Borges